KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Receivables - Other: 2011-2021

Historic Receivables - Other for Addus HomeCare (ADUS) over the last 10 years, with Q3 2021 value amounting to $565000.0.

  • Addus HomeCare's Receivables - Other rose 3262.91% to $565000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $565000.0, marking a year-over-year increase of 3262.91%. This contributed to the annual value of $528000.0 for FY2020, which is 6630.5% down from last year.
  • Per Addus HomeCare's latest filing, its Receivables - Other stood at $565000.0 for Q3 2021, which was up 3262.91% from $1.1 million recorded in Q2 2021.
  • Over the past 5 years, Addus HomeCare's Receivables - Other peaked at $2.3 million during Q4 2017, and registered a low of $126000.0 during Q1 2020.
  • Moreover, its 5-year median value for Receivables - Other was $676000.0 (2019), whereas its average is $973846.2.
  • Per our database at Business Quant, Addus HomeCare's Receivables - Other tumbled by 8136.09% in 2020 and then surged by 99444.44% in 2021.
  • Addus HomeCare's Receivables - Other (Quarter) stood at $2.3 million in 2017, then crashed by 75.99% to $564000.0 in 2018, then soared by 177.84% to $1.6 million in 2019, then crashed by 66.31% to $528000.0 in 2020, then grew by 7.01% to $565000.0 in 2021.
  • Its Receivables - Other stands at $565000.0 for Q3 2021, versus $1.1 million for Q2 2021 and $1.4 million for Q1 2021.